Deferred Tax Assets, Valuation Allowance of Cytosorbents Corp from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cytosorbents Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • Cytosorbents Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $48,267,681, a 6.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cytosorbents Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $48,267,681 +$2,933,127 +6.5% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $45,334,554 +$6,031,103 +15% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $39,303,451 +$8,061,321 +26% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q4 2021 $31,242,130 +$6,447,656 +26% 31 Dec 2021 10-K 15 Mar 2024 2023 FY
Q4 2020 $24,794,474 +$1,936,733 +8.5% 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q4 2019 $22,857,741 +$4,623,931 +25% 31 Dec 2019 10-K 10 Mar 2022 2021 FY
Q4 2018 $18,233,810 +$4,086,456 +29% 31 Dec 2018 10-K 09 Mar 2021 2020 FY
Q4 2017 $14,147,354 -$3,004,712 -18% 31 Dec 2017 10-K 05 Mar 2020 2019 FY
Q4 2016 $17,152,066 +$2,405,975 +16% 31 Dec 2016 10-K 07 Mar 2019 2018 FY
Q4 2015 $14,746,091 +$3,673,087 +33% 31 Dec 2015 10-K 08 Mar 2018 2017 FY
Q4 2014 $11,073,004 31 Dec 2014 10-K 03 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.